Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02618213
Other study ID # S-20150007
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2015
Est. completion date May 1, 2018

Study information

Verified date October 2022
Source Hospital of South West Jutland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Bronchiolitis in infants and young children often requires respiraty support. In Denmark Continous Positive Airway Pressure ( CPAP) are routinely used in children with moderate-severe bronchiolitis. The aim of the study is to compare CPAP and High Flow Oxygenation Therapy (HFOT) as tools of respiratory support in infants and young children with bronchiolitis. Infants and young children with moderate-severe bronchiolitis and are randomized to either CPAP or HFOT.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 1, 2018
Est. primary completion date May 1, 2018
Accepts healthy volunteers No
Gender All
Age group 1 Day to 24 Months
Eligibility Inclusion Criteria: - infants and children with moderate respiratoric syncytial virus bronchiolitis or other viral bronchiolitis and need of respiratory support. ( clinical decision) Exclusion Criteria: - severe bronchiolitis with P C02 > 9, decreased consciusness and risk for early progression to intensive therapy.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Optiflow Junior
Humified air are dispensed through the system. Airflow, FiO2 (Fraction of inspired oxygen) , SpO2 (peripheral capillary Oxygen saturation) and respiratory rate are noted each hour. Progression of condition might lead to change of system og mechanical ventilation. poor tolerance might lead to change of system
Continous Positive Airway Pressure
Humified air are dispensed throug the system. Airflow, FiO2, SpO2 and respiratory rate are noted each hour. Progression of condition might lead to change of system or mechanical ventilation. Poor tolerance might lead to change of system.

Locations

Country Name City State
Denmark Hospital Lillebaelt Kolding
Denmark Signe Vahlkvist Kolding

Sponsors (1)

Lead Sponsor Collaborator
Hospital of South West Jutland

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary respiration rate change in respiration rate ( RR) from preintervention value after 6 12 18 24 and 48 hour of intervention
Primary PCo2 Change in PCo2 (partial pressure of carbon dioxide)from pre intervention value after 6 12 24 and 48 hours of intervention
Primary Modified asthma score (MWAS) Change in MWAS from pre intervention value Once daily as long as intervention precedes ( 1-14 days)
Secondary treatment length duration of need of intervention ( hours) from beginning of intervention to discontinuation (1-14 days)
Secondary Hspitalization duration of hospitalisation ( days) from hospitalization to release (1-21 days)
Secondary Intervention failure. numbers of intervention failure defined as change of intervention or progression to need for intensive care/ mechanical ventilation. from beginning of intervention to discontinuation.(1-14 days)
Secondary patient acceptance of intervention VAS score of tolerance with intervention. 0 = worst possible acceptance 5 = fully acceptance daily VAS score (0-5) from beginning of intervention to discontinuation (1-14 days)
See also
  Status Clinical Trial Phase
Completed NCT01140048 - Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)